Table 2 Biodistribution of 64Cu-CB-TE2A-G-ZHER2:342, 64Cu-CB-TE2A-GEEE-ZHER2:342 and 64Cu-NODAGA-ZHER2:S1 in mice bearing HER2-positive (SKOV-3) xenografts. Data are presented as mean ± SD for four mice.
From: Molecular design of radiocopper-labelled Affibody molecules
Uptake, % ID/g | |||||||||
|---|---|---|---|---|---|---|---|---|---|
2 h | 6 h | 24 h | |||||||
64Cu-CB-TE2A-GEEE-ZHER2:342 | 64Cu-CB-TE2A-G-ZHER2:342 | 64Cu-NODAGA-ZHER2:S1 | 64Cu-CB-TE2A-GEEE-ZHER2:342 | 64Cu-CB-TE2A-G-ZHER2:342 | 64Cu-NODAGA-ZHER2:S1 | 64Cu-CB-TE2A-GEEE-ZHER2:342 | 64Cu-CB-TE2A-G-ZHER2:342 | 64Cu-NODAGA-ZHER2:S1 | |
Blood | 0.15 ± 0.03 | 0.29 ± 0.08 | 0.34 ± 0.08c | 0.09 ± 0.01 | 0.11 ± 0.01b | 0.43 ± 0.04c | 0.07 ± 0.01 | 0.10 ± 0.01b | 0.73 ± 0.04c |
Lung | 0.6 ± 0.2a | 1.2 ± 0.3b | 1.8 ± 0.2c | 0.42 ± 0.03a | 0.70 ± 0.04b | 2.3 ± 0.4c | 0.34 ± 0.05a | 0.61 ± 0.08b | 3.6 ± 0.2c |
Liver | 1.2 ± 0.1a | 8.7 ± 0.4b | 5.2 ± 0.7c | 1.2 ± 0.1a | 6.7 ± 0.8b | 5.8 ± 0.4c | 0.77 ± 0.07a | 5.1 ± 0.2b | 6.9 ± 0.6c |
Spleen | 0.40 ± 0.04a | 1.0 ± 0.1 | 0.8 ± 0.2c | 0.37 ± 0.02a | 0.78 ± 0.02b | 0.96 ± 0.08c | 0.28 ± 0.02a | 0.60 ± 0.09b | 1.6 ± 0.2c |
Stomach | 0.51 ± 0.06a | 0.9 ± 0.1 | 1.8 ± 0.2c | 0.38 ± 0.02 | 0.57 ± 0.03b | 2.0 ± 0.2c | 0.22 ± 0.04 | 0.5 ± 0.2b | 2.3 ± 0.3c |
Kidney | 364 ± 41 | 318 ± 17 | 349 ± 14 | 272 ± 18 | 252 ± 14 | 295 ± 43 | 185 ± 15a | 141 ± 11b | 111 ± 20c |
Tumor | 14 ± 5 | 17 ± 2 | 14 ± 5 | 16 ± 6 | 14 ± 3 | 12 ± 5 | 11 ± 3 | 14 ± 4 | 16 ± 5 |
Muscle | 0.12 ± 0.01a | 0.20 ± 0.03b | 0.25 ± 0.02c | 0.09 ± 0.01 | 0.13 ± 0.02b | 0.27 ± 0.02c | 0.06 ± 0.01 | 0.10 ± 0.01b | 0.38 ± 0.04c |
Bone | 0.32 ± 0.09a | 0.63 ± 0.06 | 0.5 ± 0.1c | 0.19 ± 0.03 | 0.4 ± 0.1 | 0.6 ± 0.1c | 0.14 ± 0.06a | 0.39 ± 0.08b | 0.8 ± 0.1c |
Intestines* | 1.1 ± 0.2a | 1.7 ± 0.1b | 3.5 ± 0.4c | 0.8 ± 0.1 | 1.5 ± 0.1 | 5.3 ± 0.5c | 0.3 ± 0.1a | 1.1 ± 0.4b | 5.6 ± 0.4c |